ArticleCancer immunology, immunotherapy : CII2022

Prognostic value of natural killer cell activity for patients with HER2 + advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab.

Hyungwoo Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.